Stay updated with breaking news from Generation Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Generation Bio Co. (GBIO) delivered earnings and revenue surprises of 4.08% and 88.27%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
The recent 11% drop in Generation Bio Co.'s ( NASDAQ:GBIO ) stock could come as a blow to insiders who purchased...
Generation Bio Co. (NASDAQ:GBIO – Free Report) has been given a consensus recommendation of “Moderate Buy” by the six brokerages that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month price objective […]
Generation Bio Co. (NASDAQ:GBIO – Free Report) insider Phillip Samayoa sold 3,116 shares of the business’s stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $5.29, for a total value of $16,483.64. Following the sale, the insider now owns 101,428 shares in the company, valued at approximately […]
Dr. Zhong Zhong joins Ovid as Chief Scientific Officer (CSO) and Dr. Manoj Malhotra assumes role as Chief Medical Officer (CMO) following the planned retirement of Dr. Claude NicaiseMeg Alexander promoted to Chief Strategy OfficerOvid streamlined G&A ...